Excerpt taken from “Guide to Malignant Hyperthermia in an anesthesia setting, ABC’s of Managing MH.”

A. Aware of recrudescence signs.

Ask the relatives about anesthesia problems/neuromuscular disorders.

B. Biopsy: Send the patient to a biopsy center for evaluation.

C. Contact MHAUS for further information/referral of patient.

D. Dantrolene 1 mg/kg IV q 4-6h and continued for 24-48h after an episode of Malignant Hyperthermia.

Documentation: submit forms to the national/international North American MH Registry of MHAUS